General Information of the Compound
Compound ID
CP0898479
Compound Name
5-(2-(2-(2-Fluoroethoxy)ethoxy)ethoxy)-N-(4-(4-(2-methoxy-phenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide oxalic acid
    Show/Hide
Structure
Formula
C32H43FN4O9
Molecular Weight
646.713
Canonical SMILES
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(OCCOCCOCCF)ccc3[nH]2)CC1.O=C(O)C(=O)O
    Show/Hide
InChI
InChI=1S/C30H41FN4O5.C2H2O4/c1-37-29-7-3-2-6-28(29)35-15-13-34(14-16-35)12-5-4-11-32-30(36)27-23-24-22-25(8-9-26(24)33-27)40-21-20-39-19-18-38-17-10-31;3-1(4)2(5)6/h2-3,6-9,22-23,33H,4-5,10-21H2,1H3,(H,32,36);(H,3,4)(H,5,6)
    Show/Hide
InChIKey
KQJLXUWVXSPWBV-UHFFFAOYSA-N
Physicochemical Property
logP
3.0458
Rotatable Bonds
17
Heavy Atom Count
46
Polar Areas
162.89
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
9
Complexity
46

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 76311270
ChEMBL ID
CHEMBL3133862
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 42.4 nM
   TI
   LI
   LO
   TS
Protein ID: PT00943, D(3) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 1.5 nM
   TI
   LI
   LO
   TS
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 565 nM
   TI
   LI
   LO
   TS